Gallbladder Clinical Trials
Here are the 0 most popular medical studies for gallbladder
Popular filter options for gallbladder trials
Gallbladder Clinical Trials With No Placebo
View 6 gallbladder medical studies that do not have a placebo group.
Monoclonal Antibodies
Guadecitabine + Durvalumab for Liver and Pancreatic Cancer
This trial is testing the side effects and best dosage of a new cancer drug, guadecitabine, when given with another drug, durvalumab. Guadecitabine works by blocking enzymes needed for cell growth, and durvalumab works by targeting certain cells. The hope is that the two drugs will work better together than either does alone in treating liver, pancreatic, bile duct, or gallbladder cancer.
low-fat and low cholesterol diet +2 More for Gallbladder Dysfunction
The goal of this study is to challenge the existing clinical practice of employing laparoscopic cholecystectomy as the treatment for gallbladder dyskinesia by comparing it to a regimen of active non-surgical therapy.
Frequently Asked Questions
Introduction to gallbladder
What are the top hospitals conducting gallbladder research?
When it comes to clinical trials for gallbladder conditions, several top hospitals are making strides in research and treatment. In Sacramento, the University of California Davis Comprehensive Cancer Center is leading the way with two active gallbladder trials. While they have not conducted any previous trials specifically focused on this condition, their expertise and dedication to cancer care make them a trusted institution for patients seeking innovative solutions. Similarly, the University of Florida Health Science Center in Gainesville has two ongoing gallbladder trials but no prior studies dedicated solely to this area. This center's commitment to advancing medical knowledge positions them as a valuable resource for individuals battling gallbladder issues.
In Atlanta, both Emory University Hospital Midtown and Emory University Hospital/Winship Cancer Institute are actively engaged in two clinical trials targeting gallbladder conditions. With an absence of previous all-time gallbladder trials at these institutions, they demonstrate their determination to delve into uncharted territories and improve outcomes for patients facing challenges related to the gallbladder.
Finally, located in Baltimore is Johns Hopkins University/Sidney Kimmel Cancer Center—a renowned institution that prides itself on cutting-edge research. Although they also have two ongoing gallbladder trials without any historical data on such specific studies, their involvement signifies a commitment towards enhancing understanding and treatment options for people grappling with disorders affecting the gallbladder.
These hospitals are at the forefront of promoting innovation and advancements within the field of gastroenterology by focusing their efforts on finding new strategies against diseases impacting our bile-storing organ—the gall bladder—whose significance often goes unnoticed until complications arise. Through these collaborative endeavors between healthcare professionals, researchers,and courageous participants enrolling into these pioneering programs worldwide; collectively we aim can pave pathways toward improved diagnoses,treatments,and ultimately better quality life standards even beyond those suffering from this particular condition alone
Which are the best cities for gallbladder clinical trials?
When it comes to gallbladder clinical trials, several cities stand out as leaders in research and development. Anchorage, Alaska has 8 active trials focused on treatments such as lymphadenectomy. Atlanta, Georgia follows closely behind with 6 ongoing studies investigating lymphadenectomy and cobimetinib among other options. Peoria, Illinois and Boston, Massachusetts both have 4 active trials exploring various treatment approaches including lymphadenectomy and cobimetinib. Lastly, Sacramento, California boasts 3 active trials examining treatments like lymphadenectomy and cobimetinib alongside other potential breakthroughs. These cities offer individuals battling gallbladder conditions access to cutting-edge clinical trials that pave the way for advancements in care and hope for better outcomes.
Which are the top treatments for gallbladder being explored in clinical trials?
Clinical trials are shedding light on promising treatments for gallbladder disease. One standout is daratumumab, which has shown potential in six active trials dedicated to gallbladder-related conditions. Another contender is belantamab mafodotin, currently being explored in four ongoing studies focused specifically on the gallbladder. Finally, lenalidomide remains a strong candidate, with three active clinical trials investigating its efficacy against gallbladder disease. These innovative approaches hold promise for improving treatment options and outcomes for individuals battling issues related to the gallbladder.
What are the most recent clinical trials for gallbladder?
Exciting advancements in the field of gallbladder research are shedding new light on potential treatment options. In recent clinical trials, lymphadenectomy has shown promise as a therapeutic approach for patients with gallbladder disorders. This intervention, currently in Phase 2 and Phase 3 trials, aims to improve outcomes and enhance patient care. Additionally, guadecitabine is being investigated in Phase 1 studies as a potential treatment option for gallbladder conditions. Furthermore, cobimetinib has demonstrated encouraging results in Phase 2 trials for individuals battling this disease. Lastly, laparoscopic cholecystectomy is an ongoing trial evaluating its effectiveness as a surgical procedure for the management of gallbladder disorders. These innovative studies offer hope and pave the way towards more effective treatments for those affected by gallbladder-related conditions.
What gallbladder clinical trials were recently completed?
Recently completed clinical trials have made significant strides in advancing our understanding and treatment of gallbladder conditions. Notably, a trial investigating the efficacy of Ursodeoxycholic Acid (UDCA) as a potential therapeutic option concluded successfully. Another study focusing on the use of Gemcitabine-based chemotherapy regimens also reached completion and provided valuable insights into its effectiveness for gallbladder cancer patients. These recent advancements highlight the ongoing efforts to improve outcomes and care for individuals affected by gallbladder disorders.